Publications by authors named "Margaux Marce"

Claim this Profile
R
Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1.
Frédérique Berger, Margaux Marce, Suzette Delaloge, Anne-Claire Hardy-Bessard, Thomas Bachelot

BMJ Open· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis